PMID- 24664704 OWN - NLM STAT- MEDLINE DCOM- 20140724 LR - 20220318 IS - 0065-2598 (Print) IS - 0065-2598 (Linking) VI - 801 DP - 2014 TI - Impairment of the ubiquitin-proteasome pathway in RPE alters the expression of inflammation related genes. PG - 237-50 LID - 10.1007/978-1-4614-3209-8_31 [doi] AB - The ubiquitin-proteasome pathway (UPP) plays an important role in regulating gene expression. Retinal pigment epithelial cells (RPE) are a major source of ocular inflammatory cytokines. In this work we determined the relationship between impairment of the UPP and expression of inflammation-related factors. The UPP could be impaired by oxidative stress or chemical inhibition. Impairment of the UPP in RPE increased the expression of several inflammatory cytokines, such as IL-6 and IL-8. However, the expression of monocyte chemoattractant protein-1 (MCP-1) and complement factor H (CFH) and was reduced upon impairment of the UPP. These data suggest that impairment of the UPP in RPE may be one of the causes of retinal inflammation and abnormal functions of monocyte and the complement system during the pathogenesis of age-related macular degeneration. FAU - Liu, Zhenzhen AU - Liu Z AD - Laboratory for Nutrition and Vision Research, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, USA, 723179127@qq.com. FAU - Qin, Tingyu AU - Qin T FAU - Zhou, Jilin AU - Zhou J FAU - Taylor, Allen AU - Taylor A FAU - Sparrow, Janet R AU - Sparrow JR FAU - Shang, Fu AU - Shang F LA - eng GR - R01 EY012951/EY/NEI NIH HHS/United States GR - R01 EY011717/EY/NEI NIH HHS/United States GR - EY011717/EY/NEI NIH HHS/United States GR - P30 EY019007/EY/NEI NIH HHS/United States GR - R29 EY011717/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. PL - United States TA - Adv Exp Med Biol JT - Advances in experimental medicine and biology JID - 0121103 RN - 0 (CCL2 protein, human) RN - 0 (CXCL8 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (IL6 protein, human) RN - 0 (Interleukin-6) RN - 0 (Interleukin-8) RN - 0 (Ubiquitin) RN - 80295-65-4 (Complement Factor H) RN - EC 3.4.25.1 (Proteasome Endopeptidase Complex) SB - IM MH - Cell Line MH - Chemokine CCL2/immunology/metabolism MH - Complement Factor H/immunology/metabolism MH - Humans MH - Interleukin-6/immunology/metabolism MH - Interleukin-8/immunology/metabolism MH - *Macular Degeneration/immunology/metabolism/pathology MH - Oxidative Stress/immunology MH - Proteasome Endopeptidase Complex/*metabolism MH - Retinal Pigment Epithelium/cytology/*immunology/*metabolism MH - Retinitis/immunology/metabolism/pathology MH - Ubiquitin/*metabolism PMC - PMC4828937 MID - NIHMS766870 EDAT- 2014/03/26 06:00 MHDA- 2014/07/25 06:00 PMCR- 2016/04/12 CRDT- 2014/03/26 06:00 PHST- 2014/03/26 06:00 [entrez] PHST- 2014/03/26 06:00 [pubmed] PHST- 2014/07/25 06:00 [medline] PHST- 2016/04/12 00:00 [pmc-release] AID - 10.1007/978-1-4614-3209-8_31 [doi] PST - ppublish SO - Adv Exp Med Biol. 2014;801:237-50. doi: 10.1007/978-1-4614-3209-8_31.